- Home
- ELF vs ARWR Comparison
ELF vs ARWR Comparison
Compare ELF & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELF
- ARWR
- Stock Information
- Founded
- ELF 2004
- ARWR 2003
- Country
- ELF United States
- ARWR United States
- Employees
- ELF N/A
- ARWR N/A
- Industry
- ELF Package Goods/Cosmetics
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- ELF Consumer Discretionary
- ARWR Health Care
- Exchange
- ELF Nasdaq
- ARWR Nasdaq
- Market Cap
- ELF 7.2B
- ARWR 5.9B
- IPO Year
- ELF 2016
- ARWR 1993
- Fundamental
- Price
- ELF $122.14
- ARWR $42.39
- Analyst Decision
- ELF Strong Buy
- ARWR Strong Buy
- Analyst Count
- ELF 15
- ARWR 8
- Target Price
- ELF $143.73
- ARWR $47.75
- AVG Volume (30 Days)
- ELF 1.4M
- ARWR 1.8M
- Earning Date
- ELF 11-05-2025
- ARWR 11-25-2025
- Dividend Yield
- ELF N/A
- ARWR N/A
- EPS Growth
- ELF N/A
- ARWR N/A
- EPS
- ELF 1.69
- ARWR N/A
- Revenue
- ELF $1,342,779,000.00
- ARWR $572,976,000.00
- Revenue This Year
- ELF $26.84
- ARWR $21,287.22
- Revenue Next Year
- ELF $18.01
- ARWR N/A
- P/E Ratio
- ELF $72.41
- ARWR N/A
- Revenue Growth
- ELF 18.61
- ARWR 2816.20
- 52 Week Low
- ELF $49.40
- ARWR $9.57
- 52 Week High
- ELF $150.99
- ARWR $43.69
- Technical
- Relative Strength Index (RSI)
- ELF 40.88
- ARWR 74.27
- Support Level
- ELF $124.78
- ARWR $38.65
- Resistance Level
- ELF $132.33
- ARWR $39.56
- Average True Range (ATR)
- ELF 5.66
- ARWR 2.05
- MACD
- ELF -1.08
- ARWR 0.10
- Stochastic Oscillator
- ELF 1.02
- ARWR 85.68
About ELF e.l.f. Beauty Inc.
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.